Professional
Added to YB: 2026-05-06
Pitch date: 2026-04-30
SOFW.TA [neutral]
SofWave Medical Ltd.
-27.48%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally.
Market Cap
ILS 394.8M
Pitch Price
ILS 44.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
29.33
P/E
49.52
EV/Sales
3.43
Sector
Health Care Equipment and Supplies
Category
growth
Caro-Kann Capital Portfolio Holding: SofWave Medical Ltd.
SOFW.TA (holding update): Razor-blade model, blades ~100% gross margin. Best non-invasive skin-tightening device per derms/plastic surgeons. GLP-1/Zoom/Instagram driving demand. Rev growth accelerated: 19.7%→57.8% QoQ through 4Q25. Adj EBIT margin: -2%→10.5% in FY25 (16% in Q4). Pursuing US listing to shed orphan stock status. Mgmt owns 25%, US generates >50% rev.
Read full article (2 min)